P

Psybio Therapeutics Corp
OTC:PSYBF

Watchlist Manager
Psybio Therapeutics Corp
OTC:PSYBF
Watchlist
Price: 0 USD Market Closed
Market Cap: $0

Gross Margin

0%
Current
No historical data
Comparison unavailable

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
0%
=
$0
/
$0

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
0%
=
$0
/
$0

Peer Comparison

Country Company Market Cap Gross
Margin
CA
Psybio Therapeutics Corp
XTSX:PSYB
809k CAD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
44.6B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.1B CNY
Loading...
DE
BioNTech SE
NASDAQ:BNTX
27.5B USD
Loading...
DK
Genmab A/S
CSE:GMAB
127.3B DKK
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
20B USD
Loading...
US
Incyte Corp
NASDAQ:INCY
19.6B USD
Loading...
US
Revolution Medicines Inc
NASDAQ:RVMD
18.7B USD
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Psybio Therapeutics Corp
Glance View

Market Cap
0 USD
Industry
N/A

PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-02-08. The firm is developing a new class of drugs intended for the treatment of mental health challenges and other disorders. The firm is in the process of developing its portfolio of product candidates for sale in the pharmaceutical industry. The company has developed a technology platform that enables the generation of its formulation for its lead compound psilocybin, biosynthetic psilocybin, and other targeted tryptamines through a biosynthetic process using genetically modified bacteria through collaboration with Miami University-based in Oxford, Ohio. The firm utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.

PSYBF Intrinsic Value
Not Available
P
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Back to Top